ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Weedmaps Partners with NuggMD to Launch Medical Cannabis Card Program

Weedmaps (Nasdaq: MAPS), a leading online cannabis marketplace for consumers, today announced it has partnered with NuggMD, the nation's leading online telemedicine platform for medical cannabis patients and physicians, to launch a pilot program that streamlines the medical cannabis education and application process for patients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240724636696/en/

Weedmaps Partners with NuggMD to Launch Medical Cannabis Card Initiative (Graphic: Business Wire)

Weedmaps Partners with NuggMD to Launch Medical Cannabis Card Initiative (Graphic: Business Wire)

This initiative enhances access to medical cannabis by connecting potential patients on Weedmaps with the NuggMD telehealth platform, creating a full circle e-commerce experience when the patient returns to shop and learn more about medicinal cannabis products on Weedmaps. The first phase of the program is currently active in five of the 28 states that NuggMD serves: Florida, Oklahoma, Pennsylvania, West Virginia, and Louisiana.

“We're seeing more and more potential patients shopping through Weedmaps and specifically seeking cannabis as an alternative treatment option, and we want to help these consumers easily learn about, access, and shop for medical products as safely and conveniently as possible,” said Jackie Gonzalez-Becerra, Vice President of Revenue at Weedmaps. “Through this partnership with NuggMD, medical cannabis patients will have streamlined access to educational resources, the full breadth of NuggMD’s telehealth portal, and the full-circle familiarity of coming back to Weedmaps to shop for their products — a truly holistic shopping and patient care experience.”

According to an August 2023 survey of nearly 15,000 Weedmaps users, 33% of respondents said they are more likely to use cannabis to address the symptoms of a diagnosed medical condition, with “reducing anxiety” and “relaxing” as the most common drivers of cannabis usage. NuggMD has seen similar results from their own recent cannabis consumer poll, noting that, “one in four survey participants use marijuana for pain management.”

“It's important prospective patients have an accessible, easy to use process when looking to obtain their medical cannabis approval,” said Bonni Goldstein, MD, medical director of Canna-Centers and medical advisor to Weedmaps. “There are thousands of cannabis products on the market, and it can be overwhelming for first-time patients. This partnership between NuggMD and Weedmaps connects two trusted leaders in the cannabis space as they work to help patients understand the importance of medical cannabis, and how to achieve the desired effects available through the countless strains and cannabinoids found in the plant.”

“Millions of Americans use cannabis to make their own lives better,” said Charlie Russell, Chief Revenue Officer at NuggMD. “Our mission is to help patients overcome barriers to access, and our partnership with Weedmaps works in service of that mission. We are confident that pro-cannabis regulation and policy will continue to break down these barriers, and that the industry can work together to correct the historic wrongs wrought by cannabis prohibition.”

Launched in 2008, Weedmaps was founded by two California Prop 215 medical marijuana patients as an easily accessible online directory of medical dispensaries to guide fellow medical cannabis patients in their own research. As U.S. state medical programs began expanding, and the onset of adult-use cannabis moved forward both in the U.S. and Canada, Weedmaps expanded to support emerging markets, eventually growing into the marketplace provided today.

Weedmaps users in FL, OK, PA, WV, and LA can learn more about the NuggMD pilot program by visiting Weedmaps.com, downloading the Weedmaps app or visiting www.nuggmd.com/weedmaps.

About WM Technology

Founded in 2008, WM Technology operates Weedmaps, a leading cannabis marketplace for consumers, as well as a broad set of eCommerce and compliance software solutions for cannabis businesses and brands in U.S. state-legal markets. WM Technology holds a strong belief in the power of cannabis and the importance of enabling safe, legal access to consumers worldwide.

Over the past 15 years, the Weedmaps marketplace has become a premier destination for cannabis consumers to discover and browse cannabis-related products, access daily dispensary deals, order ahead for pick-up and delivery by participating retailers (where applicable), and learn about the plant. The Company also offers eCommerce-enablement tools designed to help cannabis retailers and brands reach consumers, create business efficiency, and manage industry-specific compliance needs.

The Company is committed to advocating for full U.S. legalization, industry-wide social equity, and continued education about the plant through key partnerships and cannabis subject matter experts.

Headquartered in Irvine, California, WM Technology supports remote and hybrid work for eligible employees. Visit us at www.weedmaps.com.

About NuggMD

NuggMD is the nation’s leading medical marijuana technology platform, serving patients in Arizona, California, Connecticut, Delaware, Florida, Georgia, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, Texas, Vermont, Virginia, Washington, and West Virginia. They’ve connected over 1,300,000 patients face-to-face with their new medical marijuana doctors via their state-of-the-art telemedicine platform. They believe every human being has the right to explore the potential benefits of medical cannabis and are fully committed to helping each patient explore every option in their journey to wellness. For further information, visit https://www.nuggmd.com.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.